CryoPort, Inc. (CYRX)
Nasdaq: CYRX · Pharmaceutical Preparations · Brentwood, TN · filing with the SEC since 2005
Who owns CryoPort, Inc.
As filed with the SECHolders of 5% or more
1
Cadian Capital Management, LP holds 5.8% of Common Stock, par value $0.001 per share, as its SCHEDULE 13G/A filed Aug 14, 2026 says.
Directors and officers
8
report now, of 11 people on the record since 2011. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Cadian Capital Management, LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.001 per share · 9.97% in Feb 13, 2025
Alger Associates, Inc.
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock · reported falling below 5%, from 5.1% in May 15, 2025
Morgan Stanley
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock · reported falling below 5%
Millennium Management LLC
SCHEDULE 13G/A · filed Jul 29, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 6.5% in Feb 5, 2026
Brown Capital Management, LLC
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, Par Value $0.01 Per Share · reported falling below 5%, from 5.24% in Nov 12, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%
What CYRX reports owning in othersstakes of 5% or more, and other ties
14 subsidiaries in 9 countries, from the list filed with the 10-K filed Mar 5, 2026.
Insider tradesForm 4
16sales
0purchases
2sales on a scheduled plan
6people selling
$6.3Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window6 of 26 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Stefanovich Robert | Chief Financial Officer | 4 | $3.1M | 0 | 0 | $0 |
| Hancock Daniel M | director | 1 | $1.5M | 1 | 0 | $0 |
| Shelton Jerrell | President, CEO | 3 | $500,000 | 1 | 0 | $0 |
| Zecchini Edward J | Chief Digital and Tech Officer | 3 | $500,000 | 0 | 0 | $0 |
| Mandalam Ramkumar | director | 2 | $500,000 | 0 | 0 | $0 |
| Sawicki Mark W | Chief Scientific Officer | 3 | $200,000 | 0 | 0 | $0 |